
Mass Tort News Articles
26 articles in this category


Abbott's $670M NEC Deal Lands Mid-Trial
Abbott's $670M settlement resolves the $495M Gill verdict and claims for 2,000 more infants as the first federal NEC bellwether trial continues in Chicago.


Hair Relaxer MDL Hits 11,877 Cases as Judge Takes Over Bellwethers
The hair relaxer MDL reached 11,877 cases on July 1 (the fourth-largest MDL) after Judge Rowland took direct control of bellwether selection. Motions due Nov 16.


Video Game Addiction Suits Top 100 as California Rulings Loom
100+ video game addiction cases are coordinated in California's JCCP 5363, with arbitration and dismissal rulings expected after the JPML denied a national MDL.

Bard PowerPort MDL: Fracture Case Heads to Trial August 18
Following a split first verdict, the second Bard PowerPort bellwether (a catheter fracture case) goes to trial August 18, 2026, with 3,376 cases pending.

Depo-Provera Settlement: Pfizer Reaches Global Deal in MDL 3140
Pfizer reached a global settlement in principle in the Depo-Provera MDL on June 15, 2026, after a record 1,739 filings in June pushed the docket past 5,500 cases.

Dupixent CTCL Lawsuits: The Next Emerging MDL
Plaintiffs are moving to centralize Dupixent cutaneous T-cell lymphoma cases as an MDL after the FDA flagged a safety signal.


ByHeart Formula Botulism Cases Become MDL-3178
The first formula-linked infant botulism outbreak (48 cases across 19 states) is now a federal MDL in New York.



Roundup Settlement: $7.25B Deal Approved
Missouri judge grants preliminary approval for Bayer's $7.25B Roundup class settlement covering 65,000 cancer claims.

MDL Trends Q1 2026: Where the Cases Are
158 active MDLs, 197,965 pending cases, and 95% concentrated in the top 25 dockets. A Q1 2026 mass tort landscape snapshot.

Hair Relaxer Lawsuits Hit 11,000: 2026 Update
MDL-3060 adds 247 cases per month. Daubert motions due April 1 as bellwether trials approach for 2027.

Camp Lejeune 2026: $530M Paid, Trials Begin
The Navy has paid $530M across 2,000 offers with 90% acceptance. But 409,000 claims remain pending as bellwether trials approach.

NEC Formula Lawsuits: Trials Resume Aug 2026
Second-wave bellwether trials set after $495M state verdict. Federal judge schedules three new test cases through Feb 2027.

Paraquat Lawsuits 2026: What Firms Need to Know
Syngenta settled the first paraquat-Parkinson's trial hours before it began. 6,400 federal cases await resolution.


OCR Settlement Clarifies HIPAA 30-Day Record Access
HHS OCR's Concentra settlement highlights HIPAA's 30-day access deadline, fee limits, and what patients can do when providers delay medical records.


Depo-Provera Litigation: FDA Warning Reshapes MDL as Cases Surpass 2,100
FDA adds meningioma warning to Depo-Provera label as MDL 3140 surpasses 2,100 cases. First bellwether trial set for December 2026.

Ozempic Litigation Comprehensive Guide: August 2025 Updates and Medical Record Challenges
Guide to Ozempic litigation including Judge Marston's evidentiary ruling, NAION vision loss claims, and managing medical record requirements in MDL 3094.

Social Media Addiction Litigation Update: July 2025 MDL Progress and Bellwether Trial Preparations
Overview of social media addiction litigation in federal MDL 3047 and California state court, including algorithmic liability theories and clinical evidence requirements.

Camp Lejeune Litigation Update: July 2025 Developments and the Medical Records Challenge
Camp Lejeune litigation updates including court rulings, settlement progress, and how law firms are addressing medical records with nearly 500,000 claims filed.